OrbiMed — 2020 Investments
5 investments dated 2020 · listed companies and verified rows first · show all
Compass Therapeutics develops antibody-based therapies targeting the tumor microenvironment to treat cancer.
BiotechHealthtechCambridge, US
Board seatStephen SquintoCarl Gordon· per SEC Form D
Co-investorsBioBritF-Prime CapitalForesite CapitalvenBio PartnersVivo Capital
BiotechLexington, US
Jasbir S. Seehra(Executive Officer, Director)
BoardJulius Knowles(Director)Alon Lazarus(Director)inOhad Hammer(Director)Ran Nussbaum(Director)
Board seatCarl Gordon· per SEC Form D · $56M raise · filed Mar 2020
Co-investorsArkin CapitalForesite Capital
Spruce Biosciences develops and commercializes therapies for serious neurological and endocrine disorders with unmet medical need, with a lead investigational enzyme replacement therapy (TA-ERT) for Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B).
BiotechHealthtechSouth San Francisco, US
Javier Szwarcberg(Executive Officer, Director)Samir Gharib(Executive Officer)RICHARD KING(Executive Officer, Director)
BoardSimpson Camilla(Director)Tiba Aynechi(Director)inBali Muralidhar(Director)in
Board seatDina Chaya· per SEC Form D · $53.6M raise · filed Feb 2023
Co-investorsAisling CapitalHealthCapRiverVest Venture PartnersAbingworthNorwest Venture Partners
NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Digital HealthHardwareHealthtechMedical DevicesMountain View, US
Rebecca Kuhn(Executive Officer)Frank Fischer(Executive Officer, Director)Vince Burgess(Director)Renee Ryan(Director)Ray Larkin(Director)Greg Garfield(Director)
Co-investorsAccelmed PartnersNew Enterprise Associates (NEA)
Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis.
HardwareHealthtechMedical DevicesOakland, US
Anand Doraiswamy(Executive Officer, Director)
BoardJosh Baltzell(Director)inJan Garfinkle(Director)in
Co-investorsAphelion CapitalArboretum VenturesScientific Health DevelopmentZühlke Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.